ELVN NASDAQ
Enliven Therapeutics, Inc.
1W: -1.1%
1M: +7.3%
3M: +19.7%
YTD: +245.9%
1Y: +153.6%
3Y: +179.6%
5Y: +137.9%
$53.76
+1.02 (+1.94%)
Weekly Expected Move ±5.9%
$47
$50
$53
$56
$59
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$3.8B
52W Range14.785-55.79
Volume727,217
Avg Volume1,302,044
Beta0.26
Dividend—
Analyst Ratings
Company Info
CEORichard A. Fair
Employees61
SectorHealthcare
IndustryBiotechnology
IPO Date2020-03-12
Websiteenliventherapeutics.com
6200 Lookout Road
Boulder, CO 80301
US
Boulder, CO 80301
US
720 647 8519
About Enliven Therapeutics, Inc.
Enliven Therapeutics, Inc. is a biopharmaceutical enterprise, currently in the clinical development phase, dedicated to discovering and advancing small molecule therapeutic agents aimed at combating cancer. Its pipeline includes ELVN-001, a small molecule kinase inhibitor currently in a Phase 1 clinical trial for adult patients with chronic myeloid leukemia. Another key candidate, ELVN-002, also a small molecule kinase inhibitor, has begun a Phase 1 clinical assessment for individuals with cancers exhibiting an abnormal HER2 gene. The company's base of operations is located in Boulder, Colorado.
Latest News
What to Know About This $345,000 Enliven Insider Sale as the Stock Soars 130%
What to Know About OrbiMed's $39 Million Enliven Therapeutics Stock Sale Amid a 130% Rally
Medical Hedge Fund Sells 281,000 Shares of Enliven Theapeutics. Is it Time to Sell ELVN?
Enliven Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares
Responsive Playbooks and the ELVN Inflection - Stock Traders Daily
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Hohl Benjamin | S-Sale | 324 | $49.97 | 2026-07-17 |
| Hohl Benjamin | S-Sale | 369 | $51.48 | 2026-07-17 |
| Hohl Benjamin | S-Sale | 2,564 | $52.32 | 2026-07-17 |
| Hohl Benjamin | S-Sale | 2,638 | $53.38 | 2026-07-17 |
| Hohl Benjamin | S-Sale | 123 | $53.87 | 2026-07-17 |